: Pharmaceutical Business 
: Home Healthcare Business
| 1968 | |
Studies began at the Future Business Division. |
|---|---|---|
| 1971 | |
Research started on oxygen enrichment membranes at Teijin, Ltd. |
| 1972 | |
Pharmaceutical research started. |
| 1973 | |
Development collaboration with Boehringer Ingelheim GmbH (Germany). |
| 1974 | |
Development partnership formed with The Chemo-Sero-Therapeutic Research Institute. |
|
Medical and Pharmaceutical Division established. | |
|
Teijin Institute for Bio-Medical Research established. | |
| 1978 | |
Iwakuni Factory of the Pharmaceutical Business Unit was established. |
|
Teijin Pharmaceutical Co. established. | |
|
Marketing alliance with Fujisawa Pharmaceutical Co., Ltd. started. | |
| 1980 | |
Marketing activities started in the Tokyo area. |
| 1982 | |
Home Oxygen Therapy business started. |
| 1985 | |
Health insurance applied to Home Oxygen Therapy. |
| 1986 | |
Marketing activities started in the Kinki area. |
| 1992 | |
Teijin Biomedical Laboratory Medical Research Council established in London. |
| 1993 | |
Marketing activities started in the Tokai area. |
|
Teijin Home Healthcare Central Japan Ltd. and Teijin Home Healthcare West Japan Ltd. established. | |
| 1994 | |
Teijin Home Healthcare East Japan Ltd., Teijin Home Healthcare Tokyo Ltd., and Teijin Home Healthcare Kansai Ltd. established. |
| 1996 | |
Nationwide sales initiated. |
| 1997 | |
Teijin Home Healthcare Kyushu Ltd. established. |
| 1999 | |
Licensing agreement signed with TAP Holdings Inc. (Takeda Pharmaceuticals North America, Inc. from July, 2008) in the U.S. |
|
Home visiting nurse station established. | |
| 2000 | |
Teijin America Inc. established in the U.S. as a clinical development base. |
|
Business partnership formed with Japan Care Service Co.,Ltd. | |
| 2002 | |
Licensing agreement signed with Eli Lilly and Company (US). |
| 2003 | |
Licensing agreement signed with Ipsen Ltd. (France). |
|
Teijin Pharma Started. | |
| 2005 | |
Contract with Fujisawa Pharmaceutical Co.,Ltd.* implemented for maintenance and management of HOT equipment for patients. *Astellas Pharma Inc. in April 2005 |
|
Licensing agreement signed with Glenmark Pharmaceuticals Ltd. (India). | |
|
Development partnership formed with Nissan Chemical Industries, Ltd. | |
| 2006 | |
Teijin Home Healthcare Limited established. |
|
Teijin Pharma Consulting Co., Ltd. established in China as a base for promoting pharmaceutical and healthcare businesses. | |
|
Founded a joint venture with YUYU INC., a Korean pharmaceutical company to offer home respiratory services. | |
| 2007 | |
Development partnership formed with CHUGAI PHARMACEUTICAL CO., LTD. |
| 2008 | |
Associated Healthcare Systems, Inc. (US) acquired by Teijin Group. |
|
Business partnership formed with Dong Wha Pharm. Ind. Co., Ltd. in South Korea. | |
|
Braden Partners L.P. (US) acquired by Teijin Group. | |
|
Home Therapy Equipment, Inc. (US) acquired by Teijin Group. | |
| 2009 | |
Founded a joint venture with Laboratorios del Dr. Esteve S.A., a Spanish pharmaceutical company to manage of home respiratory therapy business in Europe. |
|
Licensing agreement signed with Bristol-Myers Squibb Company (US). | |
|
Marketing alliance with Astellas Pharma Taiwan, Inc. started. | |
|
Sublicensing agreement signed with Menarini (Italy). | |
| 2010 | |
Marketing alliance with Astellas Pharma China, Inc. and Astellas Pharma Hong Kong Co.,Ltd. started. |
